SCHEMBL1848787

SCHEMBL1848787

CN(CCF)c1ccc(C=C2C(=O)Nc3ccccc32)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 5/20 0.70
APP P05067 5/20 0.70
MAPT P10636 5/20 0.70
SNCA P37840 5/20 0.70
MEN1 O00255 2/20 0.70
ALDH1A1 P00352 2/20 0.70
MAPK1 P28482 2/20 0.70
KMT2A Q03164 2/20 0.70
TDP1 Q9NUW8 2/20 0.70
CTRC Q99895 2/20 0.70
SMN1; SMN2 Q16637 2/20 0.70
NPC1 O15118 1/20 0.70
GMNN O75496 1/20 0.70
LMNA P02545 1/20 0.70
HPGD P15428 1/20 0.70
MTOR P42345 1/20 0.70
RAB9A P51151 1/20 0.70
BLM P54132 1/20 0.70
PMP22 Q01453 1/20 0.70
NPSR1 Q6W5P4 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1848783 1.00 PDGFRB (0.70) PDGFRBAPPMAPTSNCAMEN1
SCHEMBL13394695 0.83 APP (1.00) PDGFRBAPPMAPTSNCAMEN1
SCHEMBL29363540 0.83 APP (1.00) PDGFRBAPPMAPTSNCAMEN1
SCHEMBL1982207 0.83 APP (1.00) PDGFRBAPPMAPTSNCAMEN1
SCHEMBL644678 0.83 APP (1.00) PDGFRBAPPMAPTSNCAMEN1
SCHEMBL6001142 0.80 PDGFRB (0.73) PDGFRBAPPMAPTSNCAMEN1
SCHEMBL6001545 0.78 APP (0.67) PDGFRBAPPMAPTSNCAMEN1
SCHEMBL5475545 0.76 KDR (1.00) PDGFRBAPPMAPTSNCAMEN1
SCHEMBL5475546 0.76 KDR (1.00) PDGFRBAPPMAPTSNCAMEN1
SCHEMBL16442342 0.76 KDR (1.00) PDGFRBAPPMAPTSNCAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420052-B2 Imaging agents useful for identifying AD pathology SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2013-04-16 US disclosed
EP-2323697-A2 IMAGING AGENTS USEFUL FOR IDENTIFYING AD PATHOLOGY Siemens Medical Solutions USA, Inc. (US) 2011-05-25 EP disclosed
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology SIEMENS MEDICAL SOLUTIONS USA, INC. 2010-04-22 US disclosed
WO-2010011964-A2 IMAGING AGENTS USEFUL FOR IDENTIFYING AD PATHOLOGY SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2010-01-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology APP, APBA1, PYGB PDGFRB 3401/4885APP 1/4885MAPT 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.